By targeting a newly uncovered weakness in prostate cancer cells, this could offer an improved treatment for the disease.

The effectiveness of the Interaktor app was evaluated in a randomized trial of patients undergoing radiotherapy for prostate cancer monitor and manage their symptoms.

Scientists have found a new method that could treat patients with advanced prostate cancer. Experts at The Institute of ...

Scientists have developed compounds that selectively block a crucial interaction between RAS and the enzyme PI3K, a driver of tumor growth. Scientists from the Francis Crick Institute and Vividion The ...

A double-pronged attack on advanced prostate cancer could help treat as many as two in five patients with late-stage disease, scientists have found. Using drugs that are already being used to treat ...

A major international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for ...

An international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for one ...

EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A PANEL DISCUSSION The Summit theme “unlocking the $1 Trillion Wealth transfer in Dubai” PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / October 7, ...

The researchers enrolled 92 men with recurring prostate cancer into the trial. Half received radiation alone, while the other half received the new drug plus radiation ... Kishan called the work "a ...

The potential benefits of GLP-1 medications continue to expand. New research has found that the weight loss and diabetes drugs — officially known as glucagon-like peptide 1 receptor agonists — are ...

An estimated 1 in 8 men will be diagnosed with prostate cancer in their lifetime, often after 65. And as terrifying as that number is, a diagnosis isn’t always quite what it seems. Today, the vast ...